Zura Bio Climbs on Appointment of New CEO

Investing.com -- Zura Bio Ltd (NASDAQ:ZURA) stock rose 5.4% on Wednesday after the clinical-stage biotechnology company announced the appointment of Sandeep Kulkarni, M.D. as Chief Executive Officer, effective January 21, 2026.

Dr. Kulkarni, who will continue serving as a Director of Zura, succeeds Kim Davis, J.D., who has been serving as Interim CEO since October 2025. Davis stepped in following a medical leave of absence by CEO Robert Lisicki, who is now resigning from his position and board seat.

The new CEO brings over two decades of experience in biotechnology, investment, entrepreneurship, and medicine. Most recently, he co-founded and served as CEO of Tourmaline Bio until its acquisition by Novartis, which closed in October 2025.

"I’ve been a part of the Zura journey since Day One, and I’m thrilled to be expanding my role and leading Zura through this exciting and critical period," said Dr. Kulkarni.

Dr. Kulkarni has been a member of Zura’s Board of Directors since the company’s Nasdaq listing in March 2023 and previously served as a director of Zura’s predecessor company since its inception in March 2022.

Zura Bio is developing tibulizumab, described as the first- and only-in-class bispecific antibody blocking the IL-17 and BAFF pathways for treating autoimmune diseases. According to the company, it expects two potentially transformative readouts over the next 18 months.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Wednesday’s market has seen swings in various stocks based on news and other factors. Today, stocks like Intel and AMD are rallying, while stocks like Netflix are falling. Below are highlights of some of the biggest stock movers, from mega-caps to small caps.

Mega-Cap Movers

• Intel Corp (INTC) +10.49%
• AMD (AMD); AMD appoints former Accenture CFO KC McClure to board of directors +6.57%
• Micron Tech (MU) +5.76%
• Alibaba-exch (BABA) +2.77%
• Eli Lilly And Co (LLY) +2.6%
• United Health Group (UNH) +2.56%
• Netflix, inc. (NFLX); Banks selling $8.2 billion more Netflix debt for Warner Bros bid -3.23%

Large-Cap Stock Movers

• Rambus Inc (RMBS) +15.51%
• Teledyne Technologies Inc (TDY); Teledyne imaging sensors deployed on NASA’s BlackCAT CubeSat mission +9.69%
• Arm (ARM) +8.66%
• Moderna (MRNA) +7.07%
• Datadog Inc (DDOG); Datadog to host investor day in New York on February 12 +7.12%
• Baidu-Exch (BIDU) +6.74%
• Interactive Broke (IBKR) +5.4%
• Bilibili Inc (BILI) +5.09%
• Regencell Bioscience Holdings (RGC) -1.62%

Mid-Cap Stock Movers

• Lucid Group Inc (LCID) +15.01%
• Srvsfrst Bn (SFBS); ServisFirst Bancshares beats Q4 estimates with 33% YoY EPS growth +12.35%
• Comstock Resources Inc (CRK) +7.94%
• BankUnited Inc (BKU); BankUnited shares rise nearly 7% as fourth quarter earnings beat expectations +7.98%
• Kensington Capital Acquisition (QS) +6.89%
• Nuscale Power (SMR) +6.71%
• Solaris Oilfield Infrastructure (SEI) +6.62%
• Legend Biotech Corp (LEGN) -9.5%
• Quidel Corp (QDEL) -15.37%

Small-Cap Stock Movers

• Progress Software (PRGS); Progress Software shares soar on Q4 earnings beat, strong 2026 outlook +22.09%
• AMDL (AMDL) +13.62%
• JATT Acquisition (ZURA) +7.59%
• American Resources (AREC); American resources and SAGINT mint first critical minerals token +10.41%
• Gibraltar Industries (ROCK); Gibraltar Industries warns of revenue and earnings shortfall for 2025 -16.85%
• NovaBay Pharmaceuticals Inc (NBY) -14.23%
• UVIX (UVIX) -13.27%
• Xerox Corp (XRX) -12.41%
• Dehaier Medical Systems (NEGG) -12.91%
• Diginex Inc (DGNX) -12.14%

For real-time, market-moving news, join Investing Pro.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Monday’s market has seen swings in various stocks based on news and other factors. Today, stocks like Regencell Bioscience Holdings (RGC) are rallying, while stocks like AngloGold Ashanti Ltd (AU) are falling. Below are highlights of some of the biggest stock movers, from mega-caps to small caps.

Mega-Cap Movers ($200 billion USD or higher)

• Applovin (APP) -3.37%
• Alibaba-exch (BABA) -3.06%
• Tesla Motors (TSLA) -2.6%
• Micron Tech (MU) +2.1%

Large-Cap Stock Movers ($10-$200 billion USD)

• Regencell Bioscience Holdings (RGC) +19.28%
• AngloGold Ashanti Ltd (AU) -7.45%
• Agnico-Eagle Mines (AEM) -6.42%
• Newmont Mining (NEM) -5.8%
• Coeur dAlene Mines Corp (CDE) -4.59%
• Hecla Mining Comp (HL) -4.11%
• Coca-Cola Bottlin (COKE) -4.34%
• Royal Gold Inc. (RGLD) -3.96%
• Medline Inc (MDLN) -3.61%
• Lumentum Holdings Inc (LITE) -3.99%

Mid-Cap Stock Movers ($2-$10 billion USD)

• Ultragenyx (RARE); Ultragenyx’s bone disorder treatment fails primary endpoints in trials -44.6%
• Mudrick Capital A (HYMC) -11.15%
• Bellring Brands LLC (BRBR) -9.91%
• Aura Minerals NAQ (AUGO) -8.77%
• DRDGOLD Ltd (DRD) -8.76%
• Crocs (CROX) -6.35%
• MSCI Global Gold Miners Fund (RING) -6.73%
• Northstar At Mgt (DBRG); DigitalBridge Group (DBRG) halted following Softbank rumors +9.73%
• Belite Bio ADR (BLTE) +9.51%
• Praxis Precision Medicines Inc (PRAX); FDA grants breakthrough therapy designation for Praxis’s tremor drug +13.53%

Small-Cap Stock Movers ($300 million -$2 billion USD)

• Mereo BioPharma Group (MREO); Mereo’s setrusumab fails primary endpoint in osteogenesis imperfecta trials -87.5%
• Lionheart III (SMX) -31.59%
• Thunder Bridge Capital Partners IV (CNCK) -22.7%
• Cryptyde (ORBS); Eightco authorizes $125 million share buyback program +21.02%
• TryHard Holdings (THH) +29.32%
• Galena Biopharma (SLS); SELLAS reports 72 events in Phase 3 REGAL trial, awaits final analysis +18.29%
• Autolus Therapeutics (AUTL) +14.81%
• Neuralstem (PALI); Piper Sandler initiates Palisade Bio stock with Overweight rating on IBD drug +12.33%
• JATT Acquisition (ZURA) +11.29%
• Prime Acquisition (HPK) +9.6%

For real-time, market-moving news, join Investing Pro.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Monday’s market has seen fluctuations in various stocks based on news and other factors. Today, stocks like Applovin and Alibaba are experiencing downward trends. Below are highlights of some of the biggest stock movers, from mega-caps to small caps.

Mega-Cap Movers (Market Cap $200 billion USD or higher)

• Applovin (APP) -3.53%
• Alibaba-exch (BABA) -2.55%
• Tesla Motors (TSLA) -1.98%
• Nvidia Corp (NVDA) -1.77%
• Palantir Technologies Inc (PLTR) -1.71%

Large-Cap Stock Movers (Market Cap $10-$200 billion USD)

• Regencell Bioscience Holdings (RGC) +17.9%
• AngloGold Ashanti Ltd (AU) -7.99%
• Agnico-Eagle Mines (AEM) -7.28%
• Newmont Mining (NEM) -7.14%
• Hecla Mining Comp (HL) -6.63%
• Lumentum Holdings Inc (LITE) -5.89%
• SanDisk Corp-Exch (SNDK) -4.09%
• Albemarle (ALB) -3.78%
• Medline Inc (MDLN) -3.69%
• Coeur dAlene Mines Corp (CDE) -6.7%

Mid-Cap Stock Movers (Market Cap $2-$10 billion USD)

• Ultragenyx (RARE); Ultragenyx’s bone disorder treatment fails primary endpoints in trials -41.23%
• Mudrick Capital A (HYMC) -13.71%
• Bellring Brands LLC (BRBR) -9.95%
• DRDGOLD Ltd (DRD) -9.02%
• Aura Minerals NAQ (AUGO) -7.65%
• MSCI Global Gold Miners Fund (RING) -7.35%
• 360 Finance Inc (QFIN) -5.25%
• TSLL (TSLL) -3.95%
• Northstar At Mgt (DBRG); DigitalBridge Group (DBRG) halted following Softbank rumors +9.88%
• Praxis Precision Medicines Inc (PRAX); FDA grants breakthrough therapy designation for Praxis’s tremor drug +12.15%

Small-Cap Stock Movers (Market Cap $300 million -$2 billion USD)

• Mereo BioPharma Group (MREO); Mereo’s setrusumab fails primary endpoint in osteogenesis imperfecta trials -90.12%
• Lionheart III (SMX) -30.85%
• Sigma Lithium US (SGML) -10.17%
• Dataram Corp (USAU) -10.03%
• I Mab (NBP) -9.22%
• Uxin (UXIN) -8.64%
• Cryptyde (ORBS); Eightco authorizes $125 million share buyback program +21.49%
• Neuralstem (PALI); Piper Sandler initiates Palisade Bio stock with Overweight rating on IBD drug +16.51%
• JATT Acquisition (ZURA) +11.83%
• LightPath Technol (LPTH) +5.04%

For real-time, market-moving news, join Investing Pro.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.